Researchers
Discover all researchers in life sciences
Loading researchers...
Discover all researchers in life sciences
Researcher at Research Department
Ask questions about Michiko Nakazato's research, publications, and ongoing work
Demonstrated significant alterations in serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients, with and without antidepressant treatment, highlighting the role of BDNF in depression.
Provided a comprehensive review of ghrelin, a key hormone involved in appetite regulation and energy homeostasis, contributing to the understanding of metabolic processes.
Showed decreased serum levels of D-serine in patients with schizophrenia, suggesting a potential link between D-serine and the pathophysiology of schizophrenia.
Examined cognitive flexibility in eating disorders using the Wisconsin Card Sorting Task, revealing impaired cognitive flexibility in individuals with eating disorders.
Analyzed the impact of COVID-19 lockdown on eating disorders through the COVID Isolation Eating Scale (CIES), revealing the effects of confinement on eating behaviors.
Investigated the association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders, contributing to the genetic understanding of these conditions.
Demonstrated that tropisetron improves deficits in auditory P50 suppression in schizophrenia, suggesting a potential therapeutic role for this drug.
Investigated the relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection in Japan, providing insights into public health responses.
Michiko Nakazato is a leading researcher in psychiatry, focusing on the biological and cognitive aspects of eating disorders, schizophrenia, and anxiety disorders. Her work explores the role of neurotrophic factors and cognitive behavioral therapy in mental health treatment.
Researchers with overlapping expertise and complementary work
Finding similar researchers...